Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Remus Pharmaceuticals IPO.
April 24, 2024 10:55:00 AM
Shares of SME multibagger Remus Pharmaceuticals jumped 20 percent to ... froth in smallcaps and SME market segment. The BSE SME IPO index is up by 41 percent on a year-to-date basis, while the ...
Published by : MSNJuly 16, 2024 1:30:00 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Published by : InvestingJuly 12, 2024 3:30:00 AM
Remus Pharmaceuticals Ltd share price was down by -1.63% from the previous closing price of ?2,030.70. Who are peers of Remus Pharmaceuticals Ltd? The peers of Remus Pharmaceuticals Ltd are Sun ...
Published by : Business TodayJuly 3, 2024 7:45:00 AM
Emcure Pharma to open its IPO for bidding on July 03. The company backed by Bain Capital and promoted by Namita Thapar will collect Rs 1,952.03 crore from investors.� The IPO will have both fresh ...
Published by : The Financial Express on MSNJuly 4, 2024 9:02:00 PM
Indian pharmaceutical industry is expected to reach ~US$ 130 billion by 2030. � India ranks 3rd worldwide for pharmaceutical production by volume and 14th by value. The country has an ...
Published by : India InfolineJuly 9, 2024 11:28:00 PM
Emcure Pharmaceuticals IPO listing date has been scheduled for tomorrow (Wednesday, July 10). (https://www.emcure.com/) Emcure Pharmaceuticals IPO listing date has ...
Published by : MintJuly 8, 2024 9:58:00 PM
Those who have invested in Emcure Pharmaceuticals IPO can check their allotment status online via the official websites of BSE and issue�s registrar. Emure Pharmaceuticals IPO is set to release ...
Published by : Hindustan TimesOctober 9, 2020 3:30:00 AM
InMed Pharmaceuticals (INM) has filed to raise $10 million from the sale of common stock and warrants in an uplisting / Nasdaq IPO, according to an amended registration statement. Vancouver ...
Published by : TheStreet.comJuly 4, 2024 12:39:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) Emcure ...
Published by : MintJuly 10, 2024 1:08:00 AM
Emcure Pharmaceuticals IPO listing: Ahead of the listing, Emcure Pharma IPO GMP is +352 which indicates that the company's share price was trading at a premium. Emcure Pharmaceuticals IPO listing ...
Published by : Hindustan TimesJuly 3, 2024 2:12:00 PM
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO Emcure Pharmaceuticals' FY 2024 revenue grew by 11% to Rs 6,658 crore, with profits at Rs 527 crore.
Published by : IndiatimesJuly 4, 2024 3:30:00 AM
The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.?2021.15 today. What is the Market Cap of Remus Pharmaceuticals Ltd? Market capitalization, short for market cap ...
Published by : India InfolineThe IPO Shares of Remus Pharmaceuticals Limited IPO are proposed to list on Monday, May 29, 2023 at NSE SME. The public issue of Remus Pharmaceuticals IPO was opened on May 17, 2023 and closed for subscription on May 19, 2023. Remus Pharmaceuticals IPO Listing Date and Information:
| Listing Date | Monday, May 29, 2023 |
| BSE Script Code | |
| NSE Symbol | REMUS |
| Listing In | |
| ISIN | INE0O5T01011 |
| Issue Price | ₹1229 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Remus Pharmaceuticals Limited IPO is now available online. The public issue of Remus Pharmaceuticals IPO was open on May 17, 2023 and closed for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME
.
Remus Pharmaceuticals Limited is entering in the capital market with an IPO of 388,000 Equity Shares of Rs 10 aggregating up to Rs 47.69 Crore. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
The issue opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME.
The issue of Remus Pharmaceuticals Limited opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
The Remus Pharmaceuticals IPO is proposed to open on May 17, 2023. The IPO application ends on May 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from May 17, 2023 to May 19, 2023. The Remus Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Remus Pharmaceuticals IPO will open for subscription on May 17, 2023. The public issue will close on May 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
